SEC Form SC 13G/A filed by AngioDynamics Inc. (Amendment)

1/22/24 1:31:50 PM ET

Medical/Dental Instruments

Health Care

Get the next $ANGO alert in real time by email

SC 13G/A 1 AngioDynamics_Inc.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 EXIT FILING ANGIODYNAMICS INC (NAME OF ISSUER) COMMON STOCK (TITLE OF CLASS OF SECURITIES) 03475V101 (CUSIP NUMBER) 12/31/2023 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE IS FILED: (X) RULE 13D-1 (B) ( ) RULE 13D-1 (C) ( ) RULE 13D-1 (D) *THE REMAINDER OF THIS COVER PAGE SHALL BE FILLED OUT FOR A REPORTING PERSON`S INITIAL FILING ON THIS FORM WITH RESPECT TO THE SUBJECT CLASS OF SECURITIES, AND FOR ANY SUBSEQUENT AMENDMENT CONTAINING INFORMATION WHICH WOULD ALTER THE DISCLOSURES PROVIDED IN A PRIOR COVER PAGE. THE INFORMATION REQUIRED IN THE REMAINDER OF THIS COVER PAGE SHALL NOT BE DEEMED TO BE "FILED" FOR THE PURPOSE OF SECTION 18 OF THE SECURITIES EXCHANGE ACT OF 1934 ("ACT") OR OTHERWISE SUBJECT TO THE LIABILITIES OF THAT SECTION OF THE ACT BUT SHALL BE SUBJECT TO ALL OTHER PROVISIONS OF THE ACT (HOWEVER, SEE THE NOTES). CUSIP NO:03475V101 13G Page 2 of 5 Pages 1. NAME OF REPORTING PERSON: STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON: 04-2456637 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP NOT APPLICABLE 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION BOSTON, MASSACHUSETTS 5. SOLE VOTING POWER 0 SHARES 6. SHARED VOTING POWER 962,990 7. SOLE DISPOSITIVE POWER 0 SHARES 8. SHARED DISPOSITIVE POWER 1,009,307 9. AGGREGATED AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,009,307 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES NOT APPLICABLE 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 2.53% 12. TYPE OF REPORTING PERSON HC CUSIP NO: 03475V101 13G Page 3 of 5 Pages ITEM 1. (A) NAME OF ISSUER ANGIODYNAMICS INC (B) ADDRESS OF ISSUER`S PRINCIPAL EXECUTIVE OFFICES 14 PLAZA DRIVE LATHAM NY 12110 UNITED STATES ITEM 2. (A) NAME OF PERSON FILING STATE STREET CORPORATION (B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE STATE STREET FINANCIAL CENTER 1 CONGRESS STREET, SUITE 1 BOSTON, MA 02114-2016 (FOR ALL REPORTING PERSONS) (C) CITIZENSHIP: SEE ITEM 4 (CITIZENSHIP OR PLACE OF ORGANIZATION) OF COVER PAGES (D) TITLE OF CLASS OF SECURITIES COMMON STOCK (E) CUSIP NUMBER: 03475V101 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: SEE ITEM 12(TYPE OF REPORTING PERSON) OF THE COVER PAGE FOR EACH REPORTING PERSON AND THE TABLE BELOW, WHICH EXPLAINS THE MEANING OF THE TWO LETTER SYMBOLS APPEARING IN ITEM 12 OF THE COVER PAGES. SYMBOL CATEGORY BK BANK AS DEFINED IN SECTION 3(A) (6) OF THE ACT. IC INSURANCE COMPANY AS DEFINED IN SECTION 3 (A) (19) OF THE ACT IC INVESTMENT COMPANY REGISTERED UNDER SECTION 8 OF THE INVESTMENT COMPANY ACT OF 1940. IA AN INVESTMENT ADVISOR IN ACCORDANCE WITH RULE 13D-1(B) (1) (II) (E). EP AN EMPLOYEE BENEFIT PLAN OR ENDOWMENT FUND IN ACCORDANCE WITH RULE 13D-1(B) (1) (II) (F) . HC A PARENT HOLDING COMPANY OR CONTROL PERSON IN ACCORDANCE WITH RULE 13D-1(B)(1)(II) (G). SA A SAVINGS ASSOCIATIONS AS DEFINED IN SECTION 3(B) OF THE FEDERAL DEPOSIT INSURANCE ACT (12 U.S.C. 1813). CP A CHURCH PLAN THAT IS EXCLUDED FROM THE DEFINITION OF AN INVESTMENT COMPANY UNDER SECTION 3(C)(14) OF THE INVESTMENT COMPANY ACT OF 1940. CUSIP NO:03475V101 13G Page 4 of 5 Pages ITEM 4. OWNERSHIP THE INFORMATION SET FORTH IN ROWS 5 THROUGH 11 OF THE COVER PAGE HERETO FOR EACH OF THE REPORTING PERSONS IS INCORPORATED HEREIN BY REFERENCE. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF CLASS YES ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON NOT APPLICABLE ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON SEE EXHIBIT 1 ATTACHED HERETO ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP NOT APPLICABLE ITEM 9. NOTICE OF DISSOLUTION OF GROUP NOT APPLICABLE CUSIP NO:03475V101 13G Page 5 of 5 Pages ITEM 10. CERTIFICATION BY SIGNING BELOW I CERTIFY THAT, TO THE BEST OF MY KNOWLEDGE AND BELIEF, THE SECURITIES REFERRED TO ABOVE WERE ACQUIRED AND ARE HELD IN THE ORDINARY COURSE OF BUSINESS AND WERE NOT ACQUIRED AND ARE NOT HELD FOR THE PURPOSE OR WITH THE EFFECT OF CHANGING OR INFLUENCING THE CONTROL OF THE ISSUER OF THE SECURITIES AND WERE NOT ACQUIRED AND ARE NOT HELD IN CONNECTION WITH OR AS A PARTICIPANT IN ANY TRANSACTION HAVING THAT PURPOSE OR EFFECT. SIGNATURES AFTER REASONABLE INQUIRY AND TO THE BEST OF HIS KNOWLEDGE AND BELIEF, EACH OF THE UNDERSIGNED CERTIFIES THAT THE INFORMATION SET FORTH IN THIS STATEMENT IS TRUE, COMPLETE AND CORRECT. STATE STREET CORPORATION ELIZABETH SCHAEFER SENIOR VICE PRESIDENT, DEPUTY CONTROLLER EXHIBIT 1 THE FOLLOWING TABLE LISTS THE IDENTITY AND ITEM 3 CLASSIFICATION OF EACH SUBSIDIARY OF STATE STREET CORPORATION, THE PARENT HOLDING COMPANY, THAT BENEFICIALLY OWNS THE ISSUER`S SECURITIES. PLEASE REFER TO ITEM 3 OF THE ATTACHED SCHEDULE 13G FOR A DESCRIPTION OF EACH OF THE TWO-LETTER SYMBOLS REPRESENTING THE ITEM 3 CLASSIFICATION BELOW. SUBSIDIARY ITEM 3 CLASSIFICATION SSGA FUNDS MANAGEMENT, INC. IA STATE STREET GLOBAL ADVISORS EUROPE LIMITED IA STATE STREET GLOBAL ADVISORS LIMITED IA STATE STREET GLOBAL ADVISORS TRUST COMPANY IA NOTE: ALL OF THE LEGAL ENTITIES ABOVE ARE DIRECT OR INDIRECT SUBSIDIARIES OF STATE STREET CORPORATION.

Get the next $ANGO alert in real time by email

Recent Analyst Ratings for

$ANGO

Date	Price Target	Rating	Analyst
4/5/2024	$12.00	Perform → Outperform	Oppenheimer
9/25/2023	$19.00	Buy	H.C. Wainwright
4/17/2023	$14.00 → $13.00	Strong Buy → Outperform	Raymond James
10/15/2021	$28.00 → $37.00	Hold → Buy	Canaccord Genuity
8/20/2021		Perform	Oppenheimer
7/14/2021	$24.00 → $28.00	Hold	Canaccord Genuity
7/9/2021	$27.00 → $32.00	Strong Buy	Raymond James

More analyst ratings

SEC Form SC 13G/A filed by AngioDynamics Inc. (Amendment)

1/22/24 1:31:50 PM ET

$ANGO

Medical/Dental Instruments

Health Care

Get the next $ANGO alert in real time by email

Recent Analyst Ratings for

$ANGO

Date	Price Target	Rating	Analyst
4/5/2024	$12.00	Perform → Outperform	Oppenheimer
9/25/2023	$19.00	Buy	H.C. Wainwright
4/17/2023	$14.00 → $13.00	Strong Buy → Outperform	Raymond James
10/15/2021	$28.00 → $37.00	Hold → Buy	Canaccord Genuity
8/20/2021		Perform	Oppenheimer
7/14/2021	$24.00 → $28.00	Hold	Canaccord Genuity
7/9/2021	$27.00 → $32.00	Strong Buy	Raymond James

More analyst ratings

SEC Form SC 13G/A filed by AngioDynamics Inc. (Amendment)

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for $ANGO

SEC Form SC 13G/A filed by AngioDynamics Inc. (Amendment)

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for $ANGO

$ANGO Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SVP Quality and Regulatory Nighan Warren Jr sold $49,979 worth of shares (4,060 units at $12.31), decreasing direct ownership by 9% to 41,817 units (SEC Form 4)

SVP, Chief Legal Officer Weiss Lawrence T was granted 52,697 shares (SEC Form 4)

SEC Form 3 filed by new insider Weiss Lawrence T

$ANGO Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

AngioDynamics upgraded by Oppenheimer with a new price target

H.C. Wainwright initiated coverage on AngioDynamics with a new price target

AngioDynamics downgraded by Raymond James with a new price target

$ANGO SEC Filings

AngioDynamics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

Amendment: SEC Form SCHEDULE 13G/A filed by AngioDynamics Inc.

SEC Form 10-Q filed by AngioDynamics Inc.

$ANGO Press Releases

Fastest customizable press release news feed in the world

AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism

AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial Results

AngioDynamics to Host Virtual Cardiovascular Investor Event

$ANGO Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

SVP Quality and Regulatory Nighan Warren Jr bought $5,285 worth of shares (868 units at $6.09), increasing direct ownership by 2% to 45,877 units (SEC Form 4)

EVP and CFO Trowbridge Stephen A bought $9,962 worth of shares (1,700 units at $5.86), increasing direct ownership by 0.99% to 172,711 units (SEC Form 4)

President and CEO Clemmer James C bought $120,600 worth of shares (20,000 units at $6.03), increasing direct ownership by 3% to 681,582 units (SEC Form 4)

$ANGO Leadership Updates

Live Leadership Updates

AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors

PAVmed Appoints Shaun O'Neil as Chief Operating Officer

AVITA Medical, Inc. Appoints Two New Non-Executive Members to the Board of Directors

$ANGO Financials

Live finance-specific insights

AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial Results

AngioDynamics to Host Virtual Cardiovascular Investor Event

AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event

$ANGO Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by AngioDynamics Inc.

SEC Form SC 13G/A filed by AngioDynamics Inc. (Amendment)

SEC Form SC 13G/A filed by AngioDynamics Inc. (Amendment)

Recent Analyst Ratings for
$ANGO

Recent Analyst Ratings for
$ANGO

$ANGO
Insider Trading

$ANGO
Analyst Ratings

$ANGO
SEC Filings

$ANGO
Press Releases

$ANGO
Insider Purchases

$ANGO
Leadership Updates

$ANGO
Financials

$ANGO
Large Ownership Changes